These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35490305)

  • 1. A Signature of Three microRNAs Is a Potential Diagnostic Biomarker for Glioblastoma.
    Hosein Yazdi A; Zarrinpour V; Moslemi E; Forghanifard MM
    Iran Biomed J; 2022 Jul; 26(4):301-12. PubMed ID: 35490305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
    Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
    J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Diagnostic Model for Distinguishing Benign or Malignant Bone Cancer by Mining miRNA Expression Data.
    Zhang Y; Hu J; Li T; Hao S; Wu X
    Biochem Genet; 2023 Feb; 61(1):299-315. PubMed ID: 35861903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms.
    Yang Q; Wei B; Peng C; Wang L; Li C
    Curr Res Transl Med; 2022 Jan; 70(1):103315. PubMed ID: 34837760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma.
    Zeybek A; Öz N; Kalemci S; Edgünlü T; Kızıltuğ MT; Tosun K; Tunç M; Tekin L; Erdal ME
    Curr Mol Med; 2019; 19(3):216-227. PubMed ID: 30868951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
    Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
    Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping.
    Charkiewicz R; Sulewska A; Charkiewicz A; Gyenesei A; Galik B; Ramlau R; Piwkowski C; Stec R; Biecek P; Karabowicz P; Michalska-Falkowska A; Miltyk W; Niklinski J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.
    Bo LJ; Wei B; Li ZH; Wang ZF; Gao Z; Miao Z
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3579-86. PubMed ID: 26502847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer.
    Li J; Chen Z; Li Q; Liu R; Zheng J; Gu Q; Xiang F; Li X; Zhang M; Kang X; Wu R
    PeerJ; 2024; 12():e16660. PubMed ID: 38259671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders.
    Gecys D; Dambrauskiene K; Simonyte S; Patamsyte V; Vilkeviciute A; Musneckis A; Butkute-Sliuoziene K; Lesauskaite V; Zemaitis L; Usaite D; Adomaitiene V
    Dis Markers; 2022; 2022():3004338. PubMed ID: 35178127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa-miR-106a-5p and hsa-miR-223-3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT-qPCR.
    Ranjbaran J; Safarpour H; Nomiri S; Tavakoli T; Rezaei Z; Salmani F; Larki P; Chamani E
    Cancer Med; 2023 Mar; 12(6):7005-7018. PubMed ID: 36468451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
    Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
    Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
    Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
    World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
    Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
    Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.